Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Sarah Elkourashy, Consultant in Clinical Hematology and BMT at Hamad Medical Corporation, Assistant professor of clinical medicine at Weill Cornell Medicine-Qatar, shared on LinkedIn:
”Happy to be part of ASH Conference 2025 – ASH2025
It was a pleasure reconnecting with former colleagues and engaging with peers from across the hematology community.
The meeting offered valuable insights into the latest advances in hematology and meaningful discussions on how to further enhance the care of patients with hematological disorders.
Thankful for the rich scientific exchange and collaborative environment.
Delighted to present our poster there Shehab Mohamed, Abdulrahman Al-Mashdali
Abstracts accepted:
1.Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective study cohort
Read the full article in Blood.
Authors: Rawan Dawoud, Farah Jibril, Maria Benkhadra, Sahar Nasser, Amaal Gulied, Anas Hamad, Honar Charif, Mohamed Yassin, Ruba Yasin Taha, Safaa Alazawi, Hesham Elsabah, Deena Mudawi, Sarah Elkourashy, Shereen Elazzazy
2.Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity
Read the full article in Blood.
Authors: Maria Benkhadra, Abdulrahman Al-Mashdali, Sarah Elkourashy, Anas Hamad, Shehab Mohamed, Halima El Omri, Honar Cherif
3.Caplacizumab for pediatric immune thrombotic thrombocytopenic purpura: A scoping review of current evidence
Read the full article in Blood.
Authors: Abdulrahman Al-Mashdali, Samah M Salihb, Priyadarshini Vatsyayanc, Deena Mudawi, Sarah Elkourashy, Dina Soliman, Honar Charif, Shehab Mohamed
All from ASH25 featured in Hemostasis Today.
-
May 22, 2026, 10:23Rucha Patil: Insights from The National Haemophilia Conclave 2026
-
May 22, 2026, 10:11Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
-
May 22, 2026, 10:02Greta Mulders: Nursing Leadership in Haemophilia Gene Therapy
-
May 22, 2026, 08:45Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS
-
May 22, 2026, 08:35Jason Brandon: On Lyophilized Hemostatic Supplementation at Simmons Research Day 2026
-
May 22, 2026, 08:28Inconsistent D-Dimer Assay Reporting in VTE Studies – JTH
-
May 22, 2026, 08:21Vincent Jongkind: We Invite You to Participate in a Delphi Study for a Core Outcome Set in Acute Limb Ischemia
-
May 22, 2026, 07:46Jae Hyun Byun: Spatial Transcriptomics and the Emerging Complexity of Plaque Vulnerability
-
May 22, 2026, 07:45Thom Lysen: Tracking TTS Risk After COVID-19 Viral Vector-Based Vaccines